课题基金 / 基金详情

项目摘要

项目成果

Yong Chen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity ABSTRACT This proposal aims to develop novel surrogate augmented deep predictive learning algorithms for predicting retinopathy of prematurity (ROP). The proposal directly addresses a critical clinical burden in ophthalmology that limited ROP experts are available in the United States and worldwide, yet the early detection of ROP for timely treatment has tremendous clinical benefit for infants in preventing childhood blindness. Using a unique and massive dataset with 7905 image sets collected from a longitudinal observational study of 1257 premature infants from 13 centers in North America, we plan to develop, validate, and evaluate novel analytic algorithms that hold a promise of directly improving clinical practice in the ROP care of premature infants. The overarching goals of this proposal are: (1) to develop novel methods for performing risk stratification through the surrogate augmented deep predictive learning of earliest retinal images (prior to 34 weeks postmenstrual age [PMA]) and the most important ROP risk factors (birth weight, gestational age) for early prediction of referral-warranted ROP (RW-ROP), defined as plus disease, ROP in zone I, or stage 3 ROP or greater; and (2) to optimize the ROP schedule through the surrogate augmented deep predictive learning of accumulated longitudinal retinal images for the dynamic prediction of RW-ROP. Our methods, after proper validation in future prospective studies, may serve as a useful tool for ROP risk stratification and optimization of scheduling of ROP examinations, which can reduce the burden of ROP examination for both infants and ophthalmologists while improving the eye care of premature infants for the prevention of childhood blindness. The Specific Aims to achieve these goals are: Aim #1: Develop and evaluate the surrogate augmented deep predictive learning of the earliest retinal image sets taken prior to 34 weeks PMA and demographic factors to predict RW-ROP. Accurate risk stratification through earlier prediction of RW-ROP will help identify high-risk infants for close follow-up by ophthalmologists for early detection and timely treatment of ROP, and low risk infants who are currently receiving unnecessary physically stressful retinal examinations for less frequent ROP examinations. Aim #2: Implement the surrogate augmented deep predictive learning of accumulated retinal images over time to dynamically predict RW-ROP. The dynamic prediction of the future course of ROP by deep learning of longitudinally accumulated retinal images will help optimize the schedule of ROP examinations by ophthalmologists, thus reduce the burden of ROP examinations for both infants and ophthalmologists. The successful completion of this project will lead to novel analytic algorithms of retinal images for early identification of high-risk infants for close follow-up and for optimization of ROP exam schedule, which will lead to earlier detection and timely treatment of ROP while minimizing the number of ROP exams. This research is highly feasible and potentially transformative in its global impact on the ROP care of premature infants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
  • 批准号:
    10713097
  • 项目类别:
  • 资助金额:
    $56.39万
  • 财政年份:
    2023
  • 负责人:
    Yong Chen
  • 依托单位:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
  • 批准号:
    10522570
  • 项目类别:
  • 资助金额:
    $46.47万
  • 财政年份:
    2022
  • 负责人:
    Yong Chen
  • 依托单位:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
  • 批准号:
    10707150
  • 项目类别:
  • 资助金额:
    $51.61万
  • 财政年份:
    2022
  • 负责人:
    Yong Chen
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: